Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline versus placebo in acute ischemic and hemorrhagic stroke
IRCT201601289014N90Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in stroke, ischemic stroke and intracerebral hemorrhage (ICH) comparing Citicoline with Placebo (2 arms). Primary endpoint: Clinical signs improvement. Started Feb 2016; status: completed.
02
Drugs
citicoline
03
Conditions
strokeischemic strokeintracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on IRCT201601289014N90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201601289014N90.